Table 1.

Characteristics of 1394 children enrolled in the IPPN registry

Characteristicn (%)
Male patients756 (54.2)
Primary renal diagnosis
 CAKUT646 (46.3)
 Glomerulopathy384 (27.6)
 Vasculitis127 (9.1)
 Metabolic disease28 (2.0)
 Ischemia29 (2.1)
 Other/unknown180 (12.9)
Age at RRT start
 <1 yr221 (15.9)
 1–5 yr303 (21.7)
 6–11 yr397 (28.5)
 12–18 yr456 (32.7)
 >18 yr17 (1.2)
Age at first observation
 <1 yr117 (8.4)
 1–5 yr342 (24.5)
 5–12 yr371 (26.6)
 12–18 yr510 (36.6)
 >18 yr54 (3.9)
PD modality
 CAPD341 (24.5)
 CCPD492 (35.3)
 NIPD538 (38.6)
 IPD23 (1.6)
 Biocompatible PD fluid type458 (32.9)
ESA use
 No ESA116 (8.3)
  Epoetin-α579 (41.5)
  Epoetin-β482 (34.6)
 Darbepoetin208 (14.9)
 CERA7 (0.5)
 Epoetin-δ2 (0.2)
Iron
 No iron225 (16.2)
 Oral975 (69.9)
 Intravenous154 (11.0)
 Intravenous + oral40 (2.9)
  • CAKUT, congenital anomalies of the kidney and urinary tract; RRT, renal replacement therapy; CAPD, continuous ambulatory PD; CCPD, continuous cycling PD; NIPD, nocturnal intermittent PD; IPD, intermittent PD: CERA, continuous erythropoietin receptor activator.